课题基金 / 基金详情

项目摘要

项目成果

Joel S Pachter的其他基金

相似基金

相关文献

中文摘要
翻译
趋化因子CCL2被认为是多发性硬化症(MS)的重要因素,并在 实验性自身免疫性脑脊髓炎动物模型的主要致病作用 对于MS来说,CCL2在EAE中非冗余地发挥作用,促进破坏性的积累 中枢神经系统(CNS)中的白细胞,以及可能的其他表现 神经炎,既不是这种趋化因子的致病来源(S),也不是它的部位(S)和 作用机理(S),都是已知的。当星形胶质细胞和内皮细胞被识别时 作为EAE期间CCL2的主要来源,目前还没有关于是否以及如何协调的描述 这两个细胞中的任何一个产生CCL2会导致白细胞外渗和侵袭 中枢神经实质。这一缺陷在理解MS/EAE方面留下了重大空白 发病机制,并严重影响MS的新治疗方法,因为抗CCL2的潜力 治疗在很大程度上依赖于有效地破坏特定的趋化素池(S) 负责疾病活动。因此,设计实验是为了开始测试 广义假设:CCL2的细胞特异性释放调节不同方面的 EAE期间的神经炎症。目标1将专注于执行第一个高分辨率分析 CCL2蛋白在整个EAE过程中在中枢的分布,这将提供洞察力 进入中枢来源的CCL2和血液传播的那些通讯通路 对于引导外渗至关重要的白细胞。然后,Aim 2将采用两种新颖的、细胞条件的 CCL2基因敲除系-星形胶质细胞或内皮细胞中CCL2的靶向消除-TO 确定这些细胞类型中的每一种对临床疾病的各自贡献。这些 实验将为未来的研究提供基础,通过以下方式进一步解决机制 哪种CCL2促进白细胞外溢进入中枢神经系统,并突出治疗途径 在中枢神经系统炎症性疾病期间最有效地干扰CCL2的作用。
英文摘要
The chemokine CCL2 is considered a significant factor in multiple sclerosis (MS), and plays a primary pathogenic role in experimental autoimmune encephalomyelitis (EAE), an animal model for MS. Though CCL2 nonredundantly functions in EAE to promote accumulation of destructive leukocytes in the central nervous system (CNS), as well as possibly other manifestations of neuroinflammation, neither the pathogenic source(s) of this chemokine, nor its site(s) and mechanism(s) of action, are known. And while astrocytes and endothelial cells are recognized as major sources of CCL2 during EAE, no descriptions have yet reconciled whether and how production of CCL2 by either of these cells leads to leukocyte extravasation and invasion of the CNS parenchyma. This deficiency leaves a significant void in understanding MS/EAE pathogenesis, and seriously impacts novel treatments for MS, as the potential of anti-CCL2 therapy is critically dependent on effectively disrupting the specific chemokine pool(s) responsible for disease activity. Accordingly, experiments are designed to begin testing the following broad hypothesis: Cell-specific release of CCL2 regulates discrete aspects of neuroinflammation during EAE. Aim 1 will focus on performing the first high-resolution analysis of CCL2 protein distribution in the CNS throughout the course of EAE, which will provide insight into those pathways of communication between centrally derived CCL2 and blood-borne leukocytes critical for guiding extravastion. Aim 2 will then employ two novel, cell-conditional CCL2 knockout lines - suffering targeted CCL2 elimination in astrocytes or endothelial cells - to determine the respective contributions of each of these cell types to clinical disease. These experiments will provide a foundation for future studies to further resolve the mechanisms by which CCL2 promotes leukocyte extravastion into the CNS, and highlight therapeutic avenues to most efficiently disrupt CCL2 action during CNS inflammatory disease.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.mvr.2012.12.001
发表时间: 2013-03
期刊: MICROVASCULAR RESEARCH
影响因子: 3.1
作者: [Paul, Debayon, Cowan, Ann E., Ge, Shujun, Pachter, Joel S.]
通讯作者: Pachter, Joel S.
Detailed molecular and structural characterization of the meninges: an approach combining proteomics and Imaging Mass Cytometry
Detailed molecular and structural characterization of the meninges: an approach combining proteomics and Imaging Mass Cytometry
Regulation of CNS leukocyte extravasation
Regulation of CNS leukocyte extravasation
海外基金